Both in Biotechnology
IN8bio vs BioCardia
Over the past year INAB returned −51.6% and BCDA returned −35.1%; their daily moves had a correlation of 0.16.
INAB −51.6% BCDA −35.1%Growth of $1, one year, split-adjusted
| Metric | INAB | BCDA |
|---|---|---|
| Price | $0.9100 | $0.9019 |
| Market cap | $9.0M | $13.7M |
| Today | +0.97% | +4.75% |
| 1 month | −35.0% | −13.3% |
| 6 months | −43.5% | −20.2% |
| Year to date | −61.1% | −27.8% |
| 1 year | −54.3% | −28.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $17.8M | $4.1M |
| Dividend yield | — | — |
| Volatility (60d) | 84.0% | 69.2% |
| Short % of float | 0.5% | 6.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).